$EVLV

Vanguard amends Schedule 13G/A, reports 0 shares in Evolv (NASDAQ: EVLV)

Vanguard has filed an amended Schedule 13G/A for Evolv Technologies Holdings Inc. (NASDAQ: EVLV), reporting 0 shares beneficially owned and 0% ownership as of March 13, 2026. This amendment follows an internal realignment on January 12, 2026, which enables certain Vanguard subsidiaries to report their beneficial ownership separately in reliance on an SEC release. The filing clarifies that The Vanguard Group no longer claims beneficial ownership for securities held by these reallocated subsidiaries.

Original reporting
Published Mar 27, 2026, 7:40 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 27, 2026, 8:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$EVLV
Neutral
high confidence
Mentioned
$EVLV
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$EVLVNeutralLow
01

Why it matters

The change in beneficial ownership reporting is unlikely to influence Evolv's stock price or investor sentiment significantly.

02

Market read

The news has minimal relevance to trading decisions or market movements.

03

What to watch

Potential undisclosed reasons for the ownership change, such as internal rebalancing or regulatory considerations, are not publicly detailed.

Timing: low

Background

Vanguard's ownership filings are routine disclosures that reflect internal organizational changes rather than market-moving events.

Company-level read

Ticker impact

$EVLVNeutralHigh confidence
Context

The news pertains to Vanguard's amended Schedule 13G/A for Evolv Technologies Holdings Inc., indicating a change in beneficial ownership reporting. This is a factual update but does not directly impact Evolv's stock fundamentals or trading activity.

Expected impact

Minimal to no immediate price movement expected

Evidence & confidence

Ownership reporting changes are administrative and do not signal market sentiment shifts or fundamental changes in Evolv.

Market effects

Limited impact on the technology or biotech sectors; no sector-wide implications identified.

No regional market effects anticipated.

Negligible influence on global markets.

Counterpoint

Some traders might interpret the removal of Vanguard's beneficial ownership as a sign of strategic repositioning, potentially signaling future activity; however, evidence is lacking.

Key entities

  • Vanguard

    A major global investment management company.

  • Evolv Technologies Holdings Inc.

    A company listed on NASDAQ involved in technology or biotech sectors.

Related articles

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.

$LMTMed

Pentagon pushes military contractors to accelerate production amid shortages after war on Iran

The Pentagon ordered US defense contractors to submit within 21 days plans to accelerate production of missiles and interceptors amid shortages after the first month of strikes against Iran. It cited depleted Patriot and THAAD inventories and said framework agreements with Lockheed Martin and Northrop Grumman target PAC-3 and THAAD output. Lockheed Martin received a contract up to $58.6B to triple PAC-3 production by 2030.

$NOCMed

WP: Pentagon asks defense companies to urgently ramp up weapons production

The Pentagon, via Deputy Secretary Steve Feinberg, urged U.S. defense firms to accelerate weapons output, especially ammunition, and asked executives to submit production and delivery plans within 21 days, according to The Washington Post. CSIS data cited Patriot and THAAD stockpiles falling sharply. The article notes talks with Northrop Grumman and Lockheed Martin and a Lockheed contract up to $58.6B to triple PAC-3 output by 2030.